New Approaches to Diuresis - Reprieve

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - 3ive labs, Boehringer Ingelheim, Bristol Myers Squibb, Reprieve inc., FIRE1 Sanofi, Sequana Medical, Otsuka, Abbott, Merck
• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - 3ive labs, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Astra Zeneca, Novartis, Cardionomic, MagentaMed, Reprieve inc., FIRE1, W.L. Gore, Sanofi, Sequana Medical, Merck, Windtree Therapeutics, Lexicon pharmaceuticals, Precardia, Relypsa, Regeneron,
• Equity/Stock(s)/Options (Personal) - Reprieve inc, Sequana medical